What Percentage of People Have Side Effects From Zepbound?

Introduction

Deciding to start a medical weight loss journey is a significant step toward better health, but it often comes with a mix of excitement and hesitation. Many people feel a sense of frustration after years of trying various diets and exercise routines without lasting success. When considering a highly effective medication like Zepbound®, it is natural to wonder how your body will react. At TrimRx, we prioritize your peace of mind by providing clear, evidence-based information so you can make informed decisions about your metabolic health. If you are thinking about prescription treatment, the best place to begin is to take our free assessment quiz and see whether a personalized program may fit your goals.

This post examines the clinical data surrounding tirzepatide—the active ingredient in Zepbound—to answer exactly what percentage of people experience side effects. We will explore common gastrointestinal responses, how dosage affects these numbers, and strategies for managing discomfort. For a broader look at the medication itself, our guide on what a Zepbound injection is and how it works for weight loss is a helpful companion read.

Quick Answer: In clinical trials, the most common side effects of Zepbound are gastrointestinal. Approximately 25% of patients report nausea, 19% report diarrhea, and 17% experience constipation. While these numbers seem high, most symptoms are mild to moderate and occur primarily during the initial dose-escalation phase.

The Dual Mechanism of Tirzepatide

To understand why side effects occur, it is helpful to look at how the medication works within your body. Zepbound belongs to a class of drugs known as dual agonists. Specifically, it is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (medications that mimic natural hormones). If you want a simple breakdown of the hormone side of the story, our GLP-1 explainer can help make the mechanism easier to understand.

GLP-1 is a hormone produced in the small intestine that increases insulin secretion, reduces appetite, and slows down gastric emptying—the rate at which food leaves your stomach. GIP works alongside GLP-1 to improve how the body breaks down sugar and fat. Because the medication slows down digestion to help you feel full longer, the stomach and intestines must adapt to this new pace. This “coaching” of the digestive system is the primary reason why many individuals experience temporary stomach-related symptoms.

Common Side Effects: A Percentage Breakdown

Clinical trials, such as the SURMOUNT-1 study, provided a clear map of what patients can expect when starting this medication. These trials involved thousands of participants, giving us a reliable look at the statistical likelihood of specific side effects.

Gastrointestinal Responses

The majority of reported side effects are gastrointestinal (GI) in nature. Because the medication directly impacts how the digestive tract processes food, these symptoms are often the first to appear.

• Nausea: This is the most frequently reported side effect. Approximately 25% to 33% of people experience some level of nausea, depending on their dosage.
• Diarrhea: About 19% to 23% of participants reported diarrhea during clinical trials.
• Constipation: Roughly 11% to 17% of individuals experienced constipation, likely due to the slower movement of food through the colon.
• Vomiting: Between 8% and 12% of patients reported vomiting, usually during the first few weeks of treatment or after a dose increase.
• Abdominal Pain: About 9% to 10% of people reported general stomach discomfort or pain.

Other Frequent Observations

Beyond the digestive system, other symptoms were noted by a smaller percentage of participants:

• Indigestion (Dyspepsia): Reported by approximately 9% of users.
• Fatigue: Roughly 5% to 6% of people felt increased tiredness, which may be linked to lower caloric intake or the body adjusting to metabolic changes.
• Injection Site Reactions: About 3% to 7% of people noticed redness, itching, or swelling where the medication was injected.
• Hair Loss: A small percentage (around 5%) reported thinning hair, a common occurrence during rapid weight loss known as telogen effluvium, rather than a direct side effect of the chemical itself.

Key Takeaway: Most side effects of Zepbound are digestive and occur in about 1 in 4 patients. These symptoms are typically a sign that the medication is affecting gastric emptying and are usually temporary.

How Dosage Impacts Side Effect Percentages

The frequency and intensity of side effects are often “dose-dependent,” meaning they are more likely to occur as the amount of medication increases. Zepbound is typically started at a low dose (2.5 mg) to allow the body to acclimate.

The Escalation Phase

Most clinical trials follow a “step-up” approach. For example, a patient might stay on 2.5 mg for four weeks before moving to 5 mg. Research shows that side effects peak during these transition periods. For a practical discussion of how timing and dose changes can affect symptoms, this Zepbound side effects timing guide is worth a look.

As shown in the table, nausea and vomiting tend to increase slightly as the dose gets higher. Interestingly, constipation rates sometimes decrease at the highest doses as the body finds its new equilibrium. We emphasize that a personalized approach is essential; if a certain dose causes significant distress, a healthcare provider may recommend staying at a lower dose for a longer period.

Serious but Rare Side Effects

While the common side effects are usually manageable at home, it is vital to be aware of rare but serious risks. These occurred in a very small percentage of clinical trial participants but require immediate medical attention.

Boxed Warning: Thyroid C-Cell Tumors

Zepbound carries a boxed warning because tirzepatide caused thyroid C-cell tumors in animal studies (rats and mice). It is currently unknown if the medication causes these tumors in humans. Individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use this medication.

Pancreatitis

Inflammation of the pancreas (pancreatitis) was reported in less than 1% of patients in clinical trials. Symptoms include severe abdominal pain that may radiate to the back, often accompanied by vomiting. If you want to compare different safety considerations in more detail, our Zepbound safety overview covers the bigger picture.

Gallbladder Problems

Rapid weight loss can increase the risk of gallstones or gallbladder inflammation (cholecystitis). Approximately 1% to 2% of patients may experience gallbladder-related issues. Symptoms include pain in the upper right abdomen, fever, or yellowing of the skin (jaundice).

Kidney Function and Dehydration

Severe GI side effects like vomiting and diarrhea can lead to dehydration. If left untreated, dehydration can cause acute kidney injury. It is critical to maintain high fluid intake, especially if you are experiencing stomach upset.

Important: If you experience severe, persistent abdominal pain, high fever, or signs of an allergic reaction (such as swelling of the throat or difficulty breathing), contact a healthcare professional immediately.

Managing Common Side Effects

Understanding the percentages is the first step; knowing how to handle the symptoms is the second. Most people find that simple lifestyle adjustments can significantly reduce the impact of GI issues.

Nutritional Adjustments

• Eat Smaller Meals: Instead of three large meals, try five or six small snacks throughout the day. This puts less pressure on a stomach that is emptying more slowly.
• Prioritize Protein: Focusing on lean proteins can help maintain muscle mass and keep energy levels stable without feeling overly “stuffed.”
• Avoid Trigger Foods: Greasy, fried, or highly sugary foods are more likely to cause nausea and diarrhea when taking a GLP-1/GIP receptor agonist.
• Stop When Full: Because the medication enhances satiety signals, eating past the point of fullness almost guarantees discomfort.

Hydration and Movement

• Sip, Don’t Gulp: Drink water consistently throughout the day. Rapidly gulping large amounts of fluid can lead to bloating or nausea.
• Electrolytes: If you experience diarrhea, consider an electrolyte supplement to maintain mineral balance.
• Gentle Activity: A short walk after eating can help stimulate digestion and reduce feelings of bloating or gas.

Managing Nausea and Constipation

If nausea persists, some individuals find relief through ginger tea or peppermint. For constipation, increasing fiber intake slowly and staying active are the first lines of defense. However, always consult your provider before adding new supplements to your routine. If you are looking for added nutritional support during treatment, GLP-1 Daily Support is designed for people who want help bridging nutritional gaps while they adjust.

What to Expect During the First 90 Days

The first three months are often the most telling. During this time, your body is learning to work with the medication.

Step 1: Initiation. / You will start on the lowest dose (2.5 mg). During these first four weeks, the goal is tolerability rather than massive weight loss. Step 2: Monitoring. / You and your healthcare provider will assess how you feel. If side effects are minimal, you may move to the 5 mg dose. Step 3: Stabilization. / By the third month, many patients find that their initial nausea or fatigue has begun to fade as the body’s hormones reach a steady state.

Bottom line: Most side effects peak during the first few weeks of a new dose and subside as the body acclimates to the medication’s effect on digestion.

Discontinuation Rates: Do People Stop Treatment?

One way to measure the “burden” of side effects is to look at how many people chose to stop taking the medication because of them. In the SURMOUNT-1 trial, the discontinuation rate due to adverse events was approximately 4% to 7%, depending on the dose.

Interestingly, the overall discontinuation rate (which includes people leaving the study for non-medical reasons) was around 14% to 16%. This suggests that for the vast majority of people—roughly 93% to 96%—the side effects were not severe enough to outweigh the benefits of the treatment.

Myth: “Everyone who takes Zepbound gets sick.” Fact: While about 1 in 3 may feel some nausea, only about 6% of people find the side effects bothersome enough to stop the medication entirely.

The Role of Personalized Support

Every metabolic profile is unique. What works for one person may cause discomfort for another. This is why a “one-size-fits-all” approach to weight loss often fails. We focus on creating a personalized experience that respects your body’s specific needs.

By working with licensed providers through a telehealth platform, you can report side effects in real-time and receive guidance on whether to adjust your dose or change your dietary habits. This continuous loop of support is often the difference between giving up due to nausea and successfully reaching your goal weight. For those who want extra support with energy and metabolic balance during weight loss, Weight Loss Boost can be a helpful option to explore alongside your plan.

If you are still deciding whether a medical program is right for you, our free assessment quiz can help you take the next step with clarity.

Is the Risk Worth the Result?

When looking at side effect percentages, it is helpful to look at the “success percentages” as well. In the same clinical trials where 25% of people reported nausea, participants on the highest dose lost an average of 21% of their body weight over 72 weeks. For a 230-pound person, that is a loss of nearly 50 pounds.

For many, the trade-off of a few weeks of mild nausea is worth the long-term reduction in the risk of heart disease, type 2 diabetes, and sleep apnea. Understanding the data allows you to prepare for the challenges so you can focus on the rewards.

Conclusion

The data shows that while a significant percentage of people experience side effects from Zepbound, the majority are mild, gastrointestinal, and resolve over time. Nausea, diarrhea, and constipation are the most common hurdles, affecting roughly 15% to 30% of users. However, with a slow dose escalation and proactive lifestyle changes, these symptoms can be successfully managed.

At TrimRx, our mission is to help individuals embrace healthier lifestyles through science, empathy, and a transparent, personalized approach to sustainable weight loss. We believe that by understanding the “why” and “how” of your treatment, you are better equipped to stay the course and achieve the metabolic health you deserve. If you are ready to see whether prescription treatment is a good fit, complete the free assessment quiz to review your options.

Next Step: Take our free assessment quiz to see which personalized program fits your goals and medical history.

FAQ

Does everyone get nausea on Zepbound?

No, not everyone experiences nausea. Clinical trials show that while it is the most common side effect, it affects approximately 25% to 33% of patients, meaning the majority of people do not report it. If you want to learn more about the timing of symptoms after an injection, our Zepbound side effects timing guide may help.

How long do the side effects usually last?

Most side effects are temporary and occur most frequently during the first few weeks of starting the medication or after increasing the dose. As your body adjusts to the changes in digestion, these symptoms typically subside.

Can I prevent hair loss while taking weight loss medication?

Hair loss during weight loss is usually due to the stress of rapid weight change rather than the medication itself. Ensuring you consume adequate protein and vitamins can help support hair health during your journey.

What should I do if my side effects are severe?

If you experience severe or persistent vomiting, intense abdominal pain, or signs of an allergic reaction, you should stop the medication and contact a healthcare provider immediately. If you are trying to decide whether medication-based weight loss is appropriate for you, the free assessment quiz is the best next step.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.